2013
|
Invention
|
Solid dose feeder and operating method thereof.
A solid dose feeder comprising: a plate member s... |
|
Invention
|
Solid dose feeder and operating method thereof. A solid dose feeder comprising: a plate member su... |
2009
|
Invention
|
Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 micron... |
|
Invention
|
Pharmaceutical formulation. A pharmaceutical composition comprising: a) a 5-HT1 agonist; b) an NS... |
|
Invention
|
Atovaquone with a particle size diameter range (d90) of greater than 3um to about 10um. Atovaquon... |
|
Invention
|
Atovaquone with a particle size diameter range (d90) of greater than 3 μm to about 10 μm. Atovaqu... |
|
Invention
|
Single phase pharmaceutical composition of a 5-ht1 inhibitor and an nsaid. A pharmaceutical compo... |
|
Invention
|
Delayed release pharmaceutical composition of duloxetine.
A pharmaceutical composition comprisin... |
|
Invention
|
Delayed release pharmaceutical composition of duloxetine. A pharmaceutical composition comprising... |
2008
|
Invention
|
Controlled-release pharmaceutical formulation.
A pharmaceutical formulation comprising desvenlaf... |
|
Invention
|
Controlled-release pharmaceutical formulation. A pharmaceutical formulation comprising desvenlafa... |
|
Invention
|
Pharmaceutical compound & composition. Particulate paliperidone, or a pharmaceutically accept... |
|
Invention
|
Dosage form containing two or more active pharmaceutical ingredients in different physical forms.... |
|
Invention
|
A dosage form containing two or more active pharmaceutical ingredients in different physical form... |
2007
|
Invention
|
Pharmaceutical compound and composition.
A pharmaceutical composition comprising rosiglitazone o... |
|
Invention
|
Pharmaceutical compound and composition. A pharmaceutical composition comprising rosiglitazone or... |
|
Invention
|
Pharmaceutical composition. A pharmaceutical composition comprising eplerenone having a D90 parti... |
|
Invention
|
Stabilised composition comprising ace inhibitors.
A pharmaceutical composition comprising a) an ... |
|
Invention
|
A stabilised composition comprising ace inhibitors. A pharmaceutical composition comprising a) an... |
|
Invention
|
Controlled release formulations comprising uncoated discrete unit(s) and an extended release matr... |
|
Invention
|
Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns. Oxc... |
2006
|
Invention
|
Process to control particle size. A multi-stage process to control the particle size of a pharmac... |